Bispecific antibody platforms for cancer immunotherapy

R. Lameris; R.C.G. de Bruin; F.L. Schneiders; P.M. Henegouwen; H.M.W. Verheul; T.D. de Gruijl; H.J. van der Vliet

doi:https://doi.org/10.1016/j.critrevonc.2014.08.003

Bispecific antibody platforms for cancer immunotherapy

R. Lameris, R.C.G. de Bruin, F.L. Schneiders, P.M. Henegouwen, H.M.W. Verheul, T.D. de Gruijl, H.J. van der Vliet

Research output: Contribution to journal › Article › Academic › peer-review

66 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	153-165
Journal	Critical Reviews in Oncology / Hematology
Volume	92
Issue number	3
DOIs	https://doi.org/10.1016/j.critrevonc.2014.08.003
Publication status	Published - 2014

Access to Document

https://doi.org/10.1016/j.critrevonc.2014.08.003

Cite this

@article{8e5fd1ebd9a047fe91e6015267c65dbe,

title = "Bispecific antibody platforms for cancer immunotherapy",

author = "R. Lameris and {de Bruin}, R.C.G. and F.L. Schneiders and P.M. Henegouwen and H.M.W. Verheul and {de Gruijl}, T.D. and {van der Vliet}, H.J.",

year = "2014",

doi = "https://doi.org/10.1016/j.critrevonc.2014.08.003",

language = "Undefined/Unknown",

volume = "92",

pages = "153--165",

journal = "Critical Reviews in Oncology / Hematology",

issn = "1040-8428",

publisher = "Elsevier Ireland Ltd",

number = "3",

}

TY - JOUR

T1 - Bispecific antibody platforms for cancer immunotherapy

AU - Lameris, R.

AU - de Bruin, R.C.G.

AU - Schneiders, F.L.

AU - Henegouwen, P.M.

AU - Verheul, H.M.W.

AU - de Gruijl, T.D.

AU - van der Vliet, H.J.

PY - 2014

Y1 - 2014

U2 - https://doi.org/10.1016/j.critrevonc.2014.08.003

DO - https://doi.org/10.1016/j.critrevonc.2014.08.003

M3 - Article

C2 - 25195094

SN - 1040-8428

VL - 92

SP - 153

EP - 165

JO - Critical Reviews in Oncology / Hematology

JF - Critical Reviews in Oncology / Hematology

IS - 3

ER -